Brief: Nabla Bio Signs Second Takeda Collaboration To Advance Ai-Driven Design Of Protein Therapeutics

Takeda Pharmaceutical

14/10/2025 10:00

Oct 14 (Reuters) - NABLA BIO :

NABLA BIO SIGNS SECOND TAKEDA COLLABORATION TO ADVANCE AI-DRIVEN DESIGN OF PROTEIN THERAPEUTICS

NABLA BIO: TO GET DOUBLE-DIGIT MILLIONS IN UPFRONT & RESEARCH COST PAYMENTS, ELIGIBLE TO GET SUCCESS-BASED PAYMENTS THAT MAY EXCEED $1 BILLION IN TOTAL

Source text: [ID:]

Further company coverage: 4502.T

 ((Reuters.Briefs@thomsonreuters.com;))